Wendy Huang, MD
Ophthalmology · Glendale, AZNPI 1952564114
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $67,750 of the $72,774 with a category attached, or 93.1%. Baxter Healthcare accounts for 93.1% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $34,883 and has fallen 97.2% since, to $979 in 2025. Among ophthalmology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $1347.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Baxter Healthcare$68K
- Microsurgical Technology, Inc.$3K
- Bausch & Lomb Americas Inc.$522
- Glaukos Corporation$487
- Biotissue Holdings Inc.$244
- Ocular Therapeutix, Inc.$174
- plus $820 from 11 others
What the payments were for
- Consulting fees$67,75093%
- Food & beverage$2,2473%
- Charitable contribution$2,7784%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Baxter Healthcare | 23 | $67,750 |
| Microsurgical Technology, Inc. | 1 | $2,778 |
| Bausch & Lomb Americas Inc. | 9 | $522 |
| Glaukos Corporation | 3 | $487 |
| Biotissue Holdings Inc. | 2 | $244 |
| Ocular Therapeutix, Inc. | 2 | $174 |
| ANI Pharmaceuticals, Inc. | 3 | $169 |
| Samsara Vision | 1 | $139 |
| Mallinckrodt Hospital Products Inc. | 2 | $136 |
| Dompe US, Inc. | 1 | $95 |
| AbbVie | 1 | $80 |
| Alimera Sciences, Inc. | 1 | $65 |
| Carl Zeiss Meditec USA, Inc. | 1 | $34 |
| Alcon | 1 | $28 |
| Harrow Eye, LLC | 1 | $28 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $27 |
| Genmab U.S., Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Hillrom - RetinaVue 700 Imager$67,750
- Hillrom - RetinaVue Network$67,750
- iDoseTR$270
- XIPERE$261
- KXL System$217
- VYZULTA$139
- Implantable Miniature Telescope$139
- MIEBO$129
- XIIDRA$129
- PURIFIED CORTROPHIN GEL$125
- Prokera$121
- AmnioGraft$121
How this compares
$72,774 in reported general payments places this provider in the 95th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 29 | $1,184 |
| MoxifloxacinMoxifloxacin Hcl | 23 | $712 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 24 | $289 |
| Diclofenac Sodium | 17 | $197 |
| ErythromycinErythromycin Base | 16 | $157 |
| Latanoprost | 12 | $101 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Glendale
- Shamil PatelGlendale$116K
- George ReissGlendale$73K
- Anne FloydGlendale$11K
- Warren HillMesa$1.1M
- Mark BarakatScottsdale$794K
- Anne ZakiSun City West$518K
- Pravin DugelPhoenix$176K
- Derek KunimotoMesa$138K
- Yuri McKeeMesa$100K
- Nishi ShahPhoenix$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.